×
Hologic Receivables 2010-2024 | HOLX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Hologic receivables for the quarter ending September 30, 2024 were
$0.734B
, a
1.87% increase
year-over-year.
Hologic receivables for 2024 were
$0.654B
, a
0.53% decline
from 2023.
Hologic receivables for 2023 were
$0.657B
, a
1.41% decline
from 2022.
Hologic receivables for 2022 were
$0.667B
, a
31.16% decline
from 2021.
View More
Hologic Receivables 2010-2024 | HOLX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Hologic receivables for 2024 were
$0.654B
, a
0.53% decline
from 2023.
Hologic receivables for 2023 were
$0.657B
, a
1.41% decline
from 2022.
Hologic receivables for 2022 were
$0.667B
, a
31.16% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$217.3B
Intuitive Surgical (ISRG)
$204B
Alcon (ALC)
$45.1B
Edwards Lifesciences (EW)
$42B
IQVIA Holdings (IQV)
$35.9B
IDEXX Laboratories (IDXX)
$34.3B
DexCom (DXCM)
$33.8B
Waters (WAT)
$24B
STERIS (STE)
$21.7B
SONOVA HOLDING (SONVY)
$20.8B
Fresenius Medical Care AG KGaA (FMS)
$14.6B
Globus Medical (GMED)
$12.6B
Sysmex ADR (SSMXY)
$12.2B
Penumbra (PEN)
$10.4B
Masimo (MASI)
$9.5B
Glaukos (GKOS)
$8.8B
Teleflex (TFX)
$8.4B
Integer Holdings (ITGR)
$4.8B
Inari Medical (NARI)
$4.7B
PROCEPT BioRobotics (PRCT)
$3.8B
Veracyte (VCYT)
$3.4B
LivaNova (LIVN)
$2.8B
Nihon Kohden (NHNKY)
$2.6B
Tandem Diabetes Care (TNDM)
$2.4B
Elekta AB (EKTAY)
$2.3B
TransMedics (TMDX)
$2.2B
Integra LifeSciences Holdings (IART)
$2B
Alphatec Holdings (ATEC)
$1.7B
Artivion (AORT)
$1.3B
RxSight (RXST)
$1.3B